AVITA Medical RCEL
NASDAQ RCEL
$15.49 +0.20 (+1.31%)
As of: Oct 22, 2026 · 10:26 AM EDT

AVITA Medical (RCEL) Short term Debt (2025 - 2026)

Updated

AVITA Medical (RCEL) posted Short term Debt of $46.66 million for Q2 2026.

Analysis

AVITA Medical (RCEL) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, AVITA Medical's Short term Debt came in at $42.98 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 252.57 Bn 231.60 Bn 4.88 Bn
2 Abbott Laboratories 176.08 Bn 146.51 Bn 7.27 Bn
3 Danaher 163.92 Bn 147.72 Bn 3.61 Bn
4 Intuitive Surgical 155.68 Bn 135.10 Bn 1.96 Bn
5 Medtronic 121.40 Bn 86.65 Bn 6.34 Bn
6 Stryker 117.11 Bn 103.23 Bn 4.50 Bn
7 Boston Scientific 66.70 Bn 61.47 Bn 3.85 Bn
8 Becton Dickinson 54.26 Bn 51.41 Bn 2.32 Bn
9 Edwards Lifesciences 51.46 Bn 35.46 Bn 1.35 Bn
10 AVITA Medical 478.47 Mn 410.15 Mn 17.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.66 Mn
Dec 31, 2025 42.98 Mn
Sep 30, 2025 42.45 Mn
API Access

AVITA Medical Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=RCEL&period=max&api_key=YOUR_API_KEY